Precious Metals: Time for Fear, Not Greed
Precious metals make sense as part of a long-term portfolio allocation, but today's prices are not offering an attractive entry point, says Bill Bernstein.
Precious metals make sense as part of a long-term portfolio allocation, but today's prices are not offering an attractive entry point, says Bill Bernstein.
Benz: I also want to touch on metals, which has been another big mania for investors. Gold in particular recently has come back down a little bit. But I'd like your take on precious metals as a component of investors' portfolios. Are you a believer or a naysayer?
Bernstein: I believe that in the long term precious metals should be part of most everyone's allocation. But once again, Buffett's maxim applies here, which is you want to fearful when others are greedy and greedy when others are fearful. If you are buying gold right now, you are probably buying it from someone who paid $300 an ounce for it in 1984, and so you are probably the patsy at the table if you're doing that.
Benz: The greater fool theory in operation right now. How about alternative type products, other alternatives? There has been a fascination in some quarters for all kinds of products, whether managed futures or funds that use hedging strategies. Do you think they make sense as a component of investor portfolios, or do you they are just sort of overpriced and not really going to add a lot that they couldn't get through a plain-vanilla stock bond.
Bernstein: I think that they are a wonderful way of transferring wealth from investors to traders. They have been a disaster the past five years. Think about it: Most of these funds have had fairly flat returns over the past five years, during a period, when almost any commodity you could shake a stick at has doubled or tripled in value. Why is that. Well, it's because everybody is investing in these things, everybody is going long, and so that increases the futures price relative to the spot price--you get a condition that's called contango, and so you are losing 3% to 5% per year sometimes even more versus the spot price. It's a chump's game.
Benz: So that's commodities. How about other alternative products?
Bernstein: Once again you look at the performance of alternative mutual funds over the past couple of years; they have been terrible. When people pile into any one asset class, they raise the price of the underlying assets and that decreases its future returns. The time you want to avoid any asset class is when everyone else is talking about them.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.